Gobroxia AB is a Swedish AB, operating in the Research and experimental development on biotechnology sector. Incorporated in 2017, the company has 0 employees and reported revenue of SEK 0 in its latest annual filing.
Bolagets verksamhet är att bedriva biotekniskt och biokemiskt forsknings- och utvecklingsarbete mot bakteriella toxiner i syfte att utveckla hälsokost och läkemedel, samt därmed förenlig verksamhet.
(no translation available)
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
In its most recent annual report (2019), Gobroxia AB reported revenue of SEK 0. The figures on this page draw on 3 annual filings covering 2017 to 2019. The bottom line showed a net loss of SEK 12.0k.
At the end of 2019, equity financed 87.5% of the balance sheet, and current assets covered short-term debt 8 times.
Frequently asked questions
What is the Org number of Gobroxia AB?
Gobroxia AB is registered with Bolagsverket / SCB under Org 5591084008.
